Maykin Ho insider trades
Open-market stock purchases and sales by Maykin Ho, Director at Agios Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 23, 2015.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 18, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 18, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 12, 2026 | KYNB Kyntra BIO, Inc | Bought (not open market) | — |
| Jun 2, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| May 27, 2026 | NMRA Neumora Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- AGIO Agios Pharmaceuticals, Inc: other filings, last Jun 18, 2026
- KYNB Kyntra BIO, Inc: other filings, last Jun 12, 2026
- BMRN Biomarin Pharmaceutical Inc: other filings, last Jun 2, 2026
- NMRA Neumora Therapeutics, Inc: other filings, last May 27, 2026
- FGEN Fibrogen Inc: 2 sales, last Jun 4, 2025
- PRXL Parexel International Corp: other filings, last Sep 29, 2017